Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201332
Max Phase: Preclinical
Molecular Formula: C53H93N15O12
Molecular Weight: 1132.42
Associated Items:
ID: ALA5201332
Max Phase: Preclinical
Molecular Formula: C53H93N15O12
Molecular Weight: 1132.42
Associated Items:
Canonical SMILES: CC(C)CCCCC[C@@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCN)C(=O)N[C@H]1CCNC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCN)NC(=O)[C@H](CCN)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CCN)NC1=O)[C@@H](C)O
Standard InChI: InChI=1S/C53H93N15O12/c1-29(2)13-9-7-12-16-34(58)44(71)67-43(32(6)70)53(80)64-37(19-24-56)46(73)63-39-21-26-59-52(79)42(31(5)69)68-49(76)38(20-25-57)61-45(72)35(17-22-54)62-50(77)40(27-30(3)4)65-51(78)41(28-33-14-10-8-11-15-33)66-47(74)36(18-23-55)60-48(39)75/h8,10-11,14-15,29-32,34-43,69-70H,7,9,12-13,16-28,54-58H2,1-6H3,(H,59,79)(H,60,75)(H,61,72)(H,62,77)(H,63,73)(H,64,80)(H,65,78)(H,66,74)(H,67,71)(H,68,76)/t31-,32-,34-,35+,36+,37+,38+,39+,40+,41-,42+,43+/m1/s1
Standard InChI Key: IDWJYDGVQFBVFF-HNXBOBMDSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1132.42 | Molecular Weight (Monoisotopic): 1131.7128 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Slingerland CJ, Wesseling CMJ, Innocenti P, Westphal KGC, Masereeuw R, Martin NI.. (2022) Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids., 65 (23.0): [PMID:36399613] [10.1021/acs.jmedchem.2c01528] |
Source(1):